Resistance to Afatinib and Cetuximab Combination Therapy in EGFR-mutant Lung Adenocarcinomas

被引：0
|
作者：
Pirazzoli, Valentina
Takezawa, Ken
de Stanchina, Elisa
Pao, William
Politi, Katerina
机构：
来源：
CLINICAL CANCER RESEARCH | 2012年 / 18卷 / 10期
关键词：
D O I：
10.1158/1078-0432.MECHRES-A38
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
A38
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Functional characterization and evolutionary reconstruction of small cell lung cancer transformation of EGFR-mutant lung adenocarcinomas
    Lee, June-Koo
    Park, Seongyeol
    Kim, Joon
    Kim, Tae Min
    Ju, Young Seok
    CLINICAL CANCER RESEARCH, 2018, 24 (17)
  • [42] Combined Therapy with Mutant-Selective EGFR Inhibitor and Met Kinase Inhibitor for Overcoming Erlotinib Resistance in EGFR-Mutant Lung Cancer
    Nakagawa, Takayuki
    Takeuchi, Shinji
    Yamada, Tadaaki
    Nanjo, Shigeki
    Ishikawa, Daisuke
    Sano, Takako
    Kita, Kenji
    Nakamura, Takahiro
    Matsumoto, Kunio
    Suda, Kenichi
    Mitsudomi, Tetsuya
    Sekido, Yoshitaka
    Uenaka, Toshimitsu
    Yano, Seiji
    MOLECULAR CANCER THERAPEUTICS, 2012, 11 (10) : 2149 - 2157
  • [43] Afatinib With or Without Cetuximab for EGFR-Mutant Non-Small Cell Lung Cancer: Safety and Efficacy Results from SWOG S1403
    Goldberg, S.
    Redman, M.
    Lilenbaum, R.
    Politi, K.
    Stinchcombe, T.
    Horn, L.
    Chen, E.
    Mashru, S.
    Gettinger, S.
    Melnick, M. A.
    Miao, J.
    Moon, J.
    Kelly, K.
    Gandaram, D.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S343 - S344
  • [44] Triple therapy with osimertinib, bevacizumab and cetuximab in EGFR-mutant lung cancer with HIF-1α/TGF-α expression
    Nishii, Kazuya
    Ohashi, Kadoaki
    Watanabe, Hiromi
    Makimoto, Go
    Nakasuka, Takamasa
    Higo, Hisao
    Ninomiya, Kiichiro
    Kato, Yuka
    Kubo, Toshio
    Rai, Kammei
    Ichihara, Eiki
    Hotta, Katsuyuki
    Tabata, Masahiro
    Maeda, Yoshinobu
    Kiura, Katsuyuki
    ONCOLOGY LETTERS, 2021, 22 (03)
  • [45] ACTIVITY OF AFATINIB/CETUXIMAB IN PATIENTS (PTS) WITH EGFR MUTANT NON-SMALL CELL LUNG CANCER (NSCLC) AND ACQUIRED RESISTANCE (AR) TO EGFR INHIBITORS
    Janjigian, Y. Y.
    Smit, E. F.
    Horn, L.
    Groen, H. J. M.
    Camidge, D. R.
    Gettinger, S.
    Fu, Y.
    Denis, L. J.
    Miller, V.
    Pao, W.
    ANNALS OF ONCOLOGY, 2012, 23 : 401 - 401
  • [46] Combined EGFR/MEK Inhibition Prevents the Emergence of Resistance in EGFR-Mutant Lung Cancer
    Tricker, Erin M.
    Xu, Chunxiao
    Uddin, Sharmeen
    Capelletti, Marzia
    Ercan, Dalia
    Ogino, Atsuko
    Pratilas, Christine A.
    Rosen, Neal
    Gray, Nathanael S.
    Wong, Kwok-Kin
    Jaenne, Pasi A.
    CANCER DISCOVERY, 2015, 5 (09) : 960 - 971
  • [47] Afatinib plus bevacizumab combination after osimertinib resistance in advanced EGFR-mutant non-small cell lung cancer: Phase II ABCD-study
    Hata, Akito
    Katakami, Nobuyuki
    Takase, Naoto
    Kibata, Kayoko
    Yamanaka, Yuta
    Tamiya, Motohiro
    Mori, Masahide
    Kijima, Takashi
    Morita, Satoshi
    Sakai, Kazuko
    Nishio, Kazuto
    LUNG CANCER, 2024, 197
  • [48] Optimizing the Sequence of Anti-EGFR-Targeted Therapy in EGFR-Mutant Lung Cancer
    Meador, Catherine B.
    Jin, Hailing
    de Stanchina, Elisa
    Nebhan, Caroline A.
    Pirazzoli, Valentina
    Wang, Lu
    Lu, Pengcheng
    Vuong, Huy
    Hutchinson, Katherine E.
    Jia, Peilin
    Chen, Xi
    Eisenberg, Rosana
    Ladanyi, Marc
    Politi, Katerina
    Zhao, Zhongming
    Lovly, Christine M.
    Cross, Darren A. E.
    Pao, William
    MOLECULAR CANCER THERAPEUTICS, 2015, 14 (02) : 542 - 552
  • [49] Clinical outcomes for EGFR-mutant adenocarcinomas (AC) that transform to small cell lung cancer (SCLC)
    Marcoux, N.
    Piotrowska, Z.
    Farago, A. F.
    Hata, A. N.
    Mooradian, M. J.
    Drapkin, B. J.
    Muzikansky, A.
    Gettinger, S. N.
    Mino-Kenudson, M.
    Sequist, L.
    ANNALS OF ONCOLOGY, 2017, 28
  • [50] EGFR-mutant lung adenocarcinomas mutation profiles reveal ARID1A might be a novel tyrosine kinase resistance pathway
    Gao, Xuyuan
    Xu, Hang
    Ho, James C. M.
    Chan, Oscar S. H.
    Xu, Feng
    Wang, Junwen
    Lee, Victor H. F.
    Tin, Vicky P. C.
    Xiao, Zhijie
    Wang, Siqi
    Yam, Judy W. P.
    Wong, Maria P.
    CANCER RESEARCH, 2018, 78 (13)
12345